SBC Medical Group Holdings Incorporated Cost of Revenue
SBC Medical Group Holdings Incorporated (SBC) reported Cost of Revenue of $13.21 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-08-13
- SBC Medical Group Holdings Incorporated cost of revenue for the quarter ending 2026-06-30 was $13.21M, a 1.03% decline year-over-year.
- SBC Medical Group Holdings Incorporated cost of revenue for the quarter ending 2026-03-31 was $12.71M, a 32.50% increase year-over-year.
- SBC Medical Group Holdings Incorporated cost of revenue for the quarter ending 2025-12-31 was $10.64M, a 0.85% increase year-over-year.
- SBC Medical Group Holdings Incorporated cost of revenue for the quarter ending 2025-09-30 was $12.74M, a 29.41% increase year-over-year.
- SBC Medical Group Holdings Incorporated cost of revenue for fiscal 2025 was $46.32M, a 6.16% decline from fiscal 2024.
- SBC Medical Group Holdings Incorporated cost of revenue for fiscal 2024 was $49.37M, a 12.22% decline from fiscal 2023.
- SBC Medical Group Holdings Incorporated cost of revenue for fiscal 2023 was $56.24M.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2026-06-30 | $13.21M 10-Q · filed 2026-08-13 | $25.92M 10-Q · filed 2026-08-13 | $36.56M derived: sum of 3 quarters · filed 2026-08-13 | $49.30M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $12.71M 10-Q · filed 2026-05-14 | $23.35M derived: sum of 2 quarters · filed 2026-05-14 | $36.09M derived: sum of 3 quarters · filed 2026-05-14 | $49.44M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $10.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $23.38M derived: sum of 2 quarters · filed 2026-03-27 | $36.73M derived: sum of 3 quarters · filed 2026-08-13 | $46.32M 10-K · filed 2026-03-27 |
| 2025-09-30 | $12.74M 10-Q · filed 2025-11-14 | $26.09M derived: sum of 2 quarters · filed 2026-08-13 | $35.69M 10-Q · filed 2025-11-14 | $46.23M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $13.35M 10-Q · filed 2026-08-13 | $22.94M 10-Q · filed 2026-08-13 | $33.49M derived: sum of 3 quarters · filed 2026-08-13 | $43.34M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $9.60M 10-Q · filed 2026-05-14 | $20.14M derived: sum of 2 quarters · filed 2026-05-14 | $29.99M derived: sum of 3 quarters · filed 2026-05-14 | $43.67M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $10.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $20.39M derived: sum of 2 quarters · filed 2026-03-27 | $34.08M derived: sum of 3 quarters · filed 2026-03-27 | $49.37M 10-K · filed 2026-03-27 |
| 2024-09-30 | $9.85M 10-Q · filed 2025-11-14 | $23.53M derived: sum of 2 quarters · filed 2025-11-14 | $38.82M 10-Q · filed 2025-11-14 | $57.80M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $13.68M 10-Q · filed 2025-08-13 | $28.97M 10-Q · filed 2025-08-13 | $47.95M derived: sum of 3 quarters · filed 2025-08-13 | $61.73M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $15.29M 10-Q · filed 2025-05-15 | $34.27M derived: sum of 2 quarters · filed 2025-05-15 | $48.05M derived: sum of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | $18.98M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $32.76M derived: sum of 2 quarters · filed 2025-03-28 | $56.24M 10-K · filed 2025-03-28 | |
| 2023-09-30 | $13.78M 10-Q · filed 2024-11-13 | $37.26M 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |